SPDR® S&P Pharmaceuticals ETF (XPH)
| 49.05 Delayed Data As of Apr 09 |  -0.09 / -0.18%Today’s Change | 37.54 Today|||52-Week Range 56.32 | -5.78% Year-to-Date |
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Latest XPH News
No recent news for SPDR® S&P Pharmaceuticals ETF.
Performance
| 1 month | -6.84% | 3 years | +6.78% | |
| 3 months | -8.03% | 5 years | +2.92% | |
| 1 year | +28.67% | Since inception | +9.94% |
Data through 04/10/2021
Quote Details
| Previous close | $49.14 |
| Open day’s range | 48.69 – 49.05 |
| Net asset value (NAV) | 49.04 (04/09/2021) |
| Daily volume | 65,710 |
| Average volume (3 months) | 56,441 |
Data as of 3:59pm ET, 04/09/2021
Peer Comparisonvs. Health ETFs
| XPH | Category | |
|---|---|---|
| Performance 5-yr return | +2.92% | +15.28% |
| Expense Gross exp ratio | 0.35% | 1.02% |
| Risk 5 year sharpe ratio | 0.29 | 0.80 |
| Net assets | $266.4M | $2.3B |
| Average market cap | $10.5B | $31.9B |
| Average P/E | 24.4 | 27.0 |
| Dividend / Share | -- | 0.29% |
Competitors
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| FHLC Fidelity MSCI Health Care Index ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 100.00% |
| Business service | 0.00% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| BMY Bristol-Myers Squibb | 4.39% |
| PFE Pfizer | 4.37% |
| MRK Merck | 4.36% |
| ZTS Zoetis Inc | 4.35% |
| JNJ Johnson & Johnson | 4.34% |
| HZNP Horizon Therapeutics PLC | 4.23% |
| CTLT Catalent Inc | 4.20% |
| PRGO Perrigo Company PLC | 4.16% |
| JAZZ Jazz Pharmaceuticals PLC | 4.14% |
| VTRS Viatris Inc | 4.10% |
